Spotlight on Capecitabine in the Management of Advanced Breast Cancer

By Wagstaff A.J.   Ibbotson T.   Goa K.L.  

American Journal of Cancer, Vol. 2, Iss. 2, 2003-01 ,pp. : 137-140

Adis International

Access to resources Recommend Favorite

A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden

By Andersson Jenny   Linderholm Barbro   Greim Gudrun   Lindh Birgitta   Lindman Henrik   Tennvall Jan   Tennvall-Nittby Lena   Pettersson-Sköld Dagny   Sverrisdottir Asgerdur   Söderberg Martin   Klaar Sigrid   Bergh Jonas  

Acta Oncologica, Vol. 41, Iss. 3, 2002-05 ,pp. : 276-281

Informa Healthcare

Access to resources Recommend Favorite

Impact of prophylactic pyridoxine on occurrence of hand–foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer

By Yoshimoto Nobuyasu  

Breast Cancer, Vol. 17, Iss. 4, 2010-10 ,pp. : 298-302

Springer Publishing Company

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar   Lazarev Irena   Geffen David Barry   Ariad Samuel  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite

Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer

By Wist Erik   Sommer Hilde   Østenstad Bjørn   Risberg Terje   Bremnes Yngve   Mjaaland Ingvild  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 186-189

Informa Healthcare

Access to resources Recommend Favorite